Influence of Everolimus on Steady-State Pharmacokinetics of Cyclosporine in Maintenance Renal Transplant Patients-Reference-Cited by-同舟云学术

Influence of Everolimus on Steady-State Pharmacokinetics of Cyclosporine in Maintenance Renal Transplant Patients

Published:2005-07 Issue:7 Volume:45 Page:781-791
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Budde Klemens,Lehne Gustav,Winkler Michael,Renders Lutz,Lison Arno,Fritsche Lutz,Soulillou Jean-Paul,Fauchald Per,Neumayer Hans-Hellmut,Dantal Jaques,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Review of the proliferation inhibitor everolimus;Nashan;Expert Opin Investig Drugs.,2002

2. Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction;Kovarik;Drugs Today.,2004

3. Early clinical experience with the novel rapamycin derivative;Nashan;Ther Drug Monit.,2002

4. Clinical pharmacokinetics of everolimus;Kirchner;Clin Pharmacokinet.,2004

5. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients;Neumayer;Br J Clin Pharmacol.,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Genomics of Immunosuppressive Drugs;Kidney Transplantation, Bioengineering and Regeneration;2017

2. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data;Biopharmaceutics & Drug Disposition;2015-08-20

3. Everolimus in Combination with Cyclosporin A as Pre- and Posttransplantation Immunosuppressive Therapy in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2012-07

4. Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients;Clinical Pharmacokinetics;2012-07

5. Everolimus in kidney transplantation;Transplant Research and Risk Management;2011-07